Immuno-PET imaging of guanylyl cyclase C tumor receptor expression in multiple primary human tumor explant models of colorectal and pancreatic cancer using a zirconium-89 labeled antibody

被引：0
|
作者：
Cvet, D. [1 ]
Saylor, M. [1 ]
Robertson, R. [1 ]
Terkelsen, J. [1 ]
Borland, M. [1 ]
Orcutt, K. D. [2 ]
Yardibi, O. [1 ]
Berridge, M. S. [3 ]
Salem, N. [1 ]
Hesterman, J. [2 ]
Hoppin, J. [2 ]
Bradley, D. P. [1 ]
机构：
[1] Takeda Pharmaceut Co Ltd, Cambridge, MA USA
[2] InviCRO, Boston, MA USA
[3] 3D Imaging, Little Rock, AR USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
17
引用
收藏
页码：6 / 6
页数：1
相关论文
共 7 条
  • [1] Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab
    Jagoda, Elaine M.
    Vasalatiy, Olga
    Basuli, Falguni
    Opina, Ana Christina L.
    Williams, Mark R.
    Wong, Karen
    Lane, Kelly C.
    Adler, Steve
    Ton, Anita Thein
    Szajek, Lawrence P.
    Xu, Biying
    Butcher, Donna
    Edmondson, Elijah F.
    Swenson, Rolf E.
    Greiner, John
    Gulley, James
    Eary, Janet
    Choyke, Peter L.
    MOLECULAR IMAGING, 2019, 18
  • [2] Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors
    Vera, Denis R. Beckford
    Smith, Christof C.
    Bixby, Lisa M.
    Glatt, Dylan M.
    Dunn, Stuart S.
    Saito, Ryoichi
    Kim, William Y.
    Serody, Jonathan S.
    Vincent, Benjamin G.
    Parrott, Matthew C.
    PLOS ONE, 2018, 13 (03):
  • [3] Zirconium-89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer
    Parent, Ephraim E.
    Gleba, Justyna J.
    Knight, Joshua A.
    Kenderian, Saad J.
    Copland, John A.
    Cai, Hancheng
    MOLECULAR IMAGING AND BIOLOGY, 2024, 26 (05) : 847 - 857
  • [4] Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule
    Cai, Huawei
    Shi, Qiuxiao
    Tang, Yu
    Chen, Lihong
    Chen, Yue
    Tao, Ze
    Yang, Hao
    Xie, Fang
    Wu, Xiaoai
    Liu, Nan
    Yang, Yuanyou
    Wu, Haoxing
    Tian, Rong
    Lu, Xiaofeng
    Li, Lin
    MOLECULAR PHARMACEUTICS, 2019, 16 (05) : 1950 - 1957
  • [5] Immuno-PET using Zirconium-89 (89Zr) radiolabeled fully human anti-PD-L1 antibody successfully images PD-L1 positive tumors in preclinical mouse models
    Kelly, Marcus
    Giurleo, Jason
    Makonnen, Sosina
    Hickey, Carlos
    Arnold, T. Cody
    Ma, Dangshe
    Dai, Jie
    Pei, Jerry
    Tavare, Richard
    Kirshner, Jessica
    Olson, William
    Thurston, Gavin
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [6] Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of 89Zr-Labeled Anti-PD-L1 Antibody Formats
    Bouleau, Alizee
    Nozach, Herve
    Dubois, Steven
    Kereselidze, Dimitri
    Chevaleyre, Celine
    Wang, Cheng-, I
    Evans, Michael J.
    Lebon, Vincent
    Maillere, Bernard
    Truillet, Charles
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (08) : 1259 - 1265
  • [7] Immuno PET imaging of PD-L1 expression in syngeneic and human xenograft tumor mouse models using a site-specific 89Zr labeled PD-L1 antibody
    Christensen, Camilla
    Kristensen, Lotte K.
    Toftevall, Hanna
    Nordgren, Maria
    Agnew, Brian J.
    Nielsen, Carsten H.
    Kjaer, Andreas
    CANCER RESEARCH, 2018, 78 (13)
1